In this monograph about gene therapy of autoimmune and inflammatory d- orders we have gathered international experts and leaders from different fields to review the state of the art advances on topics ranging from disease entities to vectors and engineered cells. The different approaches described in each chapter take into consideration the biomedical knowledge of these diseases and address the complexities of delivering long-term genetic interventions. Gene therapy also serves as a testing ground for new therapeutic entities and helps provide proof of principle for their potential therapeutic role in animal models of disease. Scaling up from mice to men still remains an important h- dle not only from the quantitative point of view, but also for currently unknown and unexpected secondary effects of the vector or the transgene. Some of these approaches have already been tested in the clinic, but much more needs to be done to understand the human conditions treated and the n- ural history of their pathology. We are indebted to the secretarial assistance of Ms. Lin Wells (Bone and Joint Research Unit, London, UK) and the help of Hans Detlef Klüber for his help in getting this book published. We hope this book will be of interest to c- nicians and scientists and inspiring to students of the subject who will use their own ingenuity and knowledge to further forward this discipline into clinical use.

The information is quite extensive and useful. Each chapter is well referenced. This monograph is highly specialized but is easily understandable. It is recommended for all researchers - both clinical and non-clinical, particularly those working in the fields of gene therapy, immunology, rheumatology, pharmacology and molecular medicine. It will also be a useful reference source for the libraries of all advanced academic centers and research institutions. (S. S. Agarwal, Indian Journal of Medical Research, Vol. 135, April, 2012)

This monograph contains new and valuable information regarding relevant topics ranging from disease entities to vectors and engineered cells. The authors, all of them international experts, take into consideration the biomedical knowledge of these diseases and address the complexities of delivering long termgenetic interventions. The present volume is of an exceptional value for clinicians and scientists interested in introducing gene therapy into clinical use. (Magdalena Moisei, Romanian Journal of Biochemistry, Vol. 47 (2), 2010)

Klappentext

This book addresses the latest advances in viral and non-viral vectors, novel targets and methods for the treatment of autoimmune and inflammatory disease with a main focus in pre-clinical testing with up to date clinical trials. The first section of the book deals with current research approaches for treating rheumatoid arthritis, osteoarthritis, diabetes, Crohn's disease, multiple sclerosis, Sjögrens syndrome, cystic fibrosis, myositis and lupus. The second section is devoted to cell delivery and vector development including plasmids, regulated promoters, adenovirus gutted vectors and adeno-associated vectors. All chapters are summarised by leaders in these fields. A must read for post graduate students, clinical and non-clinical researchers in the disciplines of immunology, molecular medicine, pharmacology, gene and cell-mediated therapy. TOC:From the contents: Rheumatoid arthritis.- Crohn's disease/IBD.- Diabetes.- Cystic fibrosis.- Multiple sclerosis.- Myositis.- Osteoarthritis.- Sjögrens syndrome.- Lupus.- New developments in vectors:Regulated promoters.- AAV Vectors.- Plasmid delivery.- Gutted adenovirus.- Cells as carriers of gene therapy including stem cells.- Perspectives for the future developments of gene therapy for autoimmune and inflammatory therapy.

Inhalt
Gene therapy for arthritis.- Gene therapy for the treatment of inflammatory bowel disease.- Gene therapy for diabetes.- Gene therapy for cystic fibrosis lung disease.- Gene therapy of multiple sclerosis.- Gene therapy for myositis.- Gene therapy for osteoarthritis.- Gene therapy: Sjögren's syndrome.- Disease mechanisms, genetic susceptibility and therapeutic approaches in lupus disease.- Regulated promoters.- Development of AAV vectors for the therapy of autoimmune and inflammatory diseases.- Delivery and application of plasmid DNA in arthritis gene therapy.- Helper-dependent adenoviral vectors.- Cells as carriers of gene therapy.- Perspectives for the future developments of gene therapy for autoimmune and inflammatory therapy.